401
Views
1
CrossRef citations to date
0
Altmetric
The NISS Special Series: The NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions

Rejoinder: Estimands and their Estimators for Clinical Trials Impacted by the COVID-19 Pandemic: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions

ORCID Icon, ORCID Icon, , , , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 119-124 | Received 15 Dec 2022, Accepted 22 Dec 2022, Published online: 07 Feb 2023
 

We would like to thank the discussants Mouna Akacha, Tianmeng Lyu, and Stijn Vansteelandt for their interesting and thoughtful comments on our paper “Estimators for Clinical Trials Impacted by the COVID-19 Pandemic: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions.” (Van Lancker et al., Citation2022). We also would like to extend our gratitude to Toshimitsu Hamasaki for making this a discussion article.

Additional information

Funding

The author(s) reported there is no funding associated with the work featured in this article.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 61.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 71.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.